CELZ — Creative Medical Technology Holdings Inc
NASDAQ · Healthcare · Biotechnology
$1.13
+$0.03 (+2.73%)
Creative Medical Technology Holdings Inc (CELZ) is a biotechnology company listed on NASDAQ. It is led by Timothy Warbington, based in 211 East Osborn Road, Phoenix, AZ, United States, 85012, with about 4 employees. Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Latest reported CELZ revenue for 2025-09-30 was $0. Net income was -$1.2M. CELZ currently screens at market cap $8.3M.
Use this CELZ page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CELZ quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CELZ SEC filings page. Lician reads the product cache first so this HTML stays unique to Creative Medical Technology Holdings Inc even when a live quote feed is slow.
About Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
CELZ Key Statistics
Market Cap
$8.28M
Volume
104,878
Previous Close
$1.14
Day Range
$1.09 – $1.15
P/B Ratio
1.36
EPS
-$3.71
Revenue
$11.00K
Net Income
-$5.49M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+22.2%
Profit Margin
-49940.7%
Employees
4
CELZ Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $11.00K | $9.00K | $88.60K | $87.75K |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$5.49M | -$5.29M | -$10.14M | $19.21M |
| EPS (Diluted) | -$3.71 | -$3.76 | -$0.93 | $5.61 |
Total Assets
$6.67M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$0.00
Operating Cash Flow
-$5.30M
Free Cash Flow
$0.00
Creative Medical Technology Holdings Inc Company Information
- Co-Founder, Chairman, President & CEO
- Timothy Warbington
- Headquarters
- 211 East Osborn Road, Phoenix, AZ, United States, 85012
- Phone
- 480 399 2822
- IPO / Founded
- 2015-11-06
- Sector
- Healthcare
- Industry
- Biotechnology